JVJean-Marc Vrigneaud

Jean-Marc Vrigneaud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Marc Vrigneaud has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimising $^{90}Y$ PET imaging for dosimetry in SIRT: insights from phantom and simulation studies on the Discovery MI scanner

    by Farzam Sayah, Benoît Presles, Hussein Harb, Tien-Phong Pham, Jean-Louis Alberini, Romain Popoff, Jean-Marc Vrigneaud

    The aim of this study was to optimise the acquisition and reconstruction parameters for [Formula: see text] imaging on a digital PET scanner (Discovery MI 4-ring) under high (3 GBq), intermediate (1 GBq), and low (200 MBq) activity conditions. First, quantitative linearity was evaluated. Then, NEMA IEC body phantom acquisitions were reconstructed using various scan durations and Q.Clear reconstruction parameters. Next, optimal protocols were identified by minimising the discrepancies between absorbed dose maps derived from images (using the Local Deposition Model (LDM)) and those obtained from Monte Carlo (MC) simulations. The images reconstructed with these optimal protocols were then used to evaluate effective spatial resolution and to compare the accuracy of LDM with that of the Dose Voxel Kernel (DVK) approach. Quantitative linearity analysis revealed an underestimation of phantom activity at high activity (up to - 15.7% at 3.6 GBq) and an overestimation at lower levels (up to 52.1% at 208 MBq). At high activity, the most accurate results were produced by 15- and 20-minute acquisitions with intermediate beta values (2000-5000). In contrast, intermediate and low activity levels required longer acquisition times and higher beta values (> 6000). Effective spatial resolution ranged from 7 mm at high activity to 24.9 mm at low activity. In terms of absorbed dose accuracy, the mean absorbed dose was underestimated in all spheres of the phantom. However, the error in the mean absorbed dose could be kept within 10% in the background by applying non-linearity corrections. Using MC as reference, LDM achieved greater accuracy in terms of mean absorbed dose and Dose Volume Histogram (DVH) agreement in the spheres, while DVK performed better in the background. This study enabled the optimisation of scan duration and beta parameter values for Q.Clear reconstructions for dosimetric purposes. Although accurate dosimetry remains challenging in [Formula: see text] PET imaging due to quantitative nonlinearity and limited spatial resolution, an error of less than 10% on the mean absorbed dose can be achieved in large structures if model-specific nonlinearities are corrected for.

  • Open Access

    Assessing the suitability of automated registration and segmentation for dosimetry calculations in SIRT treatment planning

    by Félix Quinton, Romain Popoff, Fabrice Meriaudeau, Jean-Marc Vrigneaud, Olivier Chevallier, Julie Pellegrinelli, Jean-Louis Alberini, Benoit Presles

    Background: Selective internal radiation therapy (SIRT) increasingly relies on accurate magnetic resonance imaging (MRI) to computed tomography (CT) registration and accurate liver and tumour segmentation, for effective pre-treatment planning. This study evaluates the impact of automatic registration and segmentation techniques on dosimetry calculations for SIRT treatment planning. It compares semi-automatic and automatic registration, as well as manual and automatic deep learning-based segmentation. Methods: Pre-treatment data from 90 patients with hepatocellular carcinoma were analysed. The dataset consisted of contrast-enhanced T1-weighted MRI scans with manually delineated liver and tumour volumes of interest (VOIs), as well as single-photon emission computed tomography (SPECT)/CT scans with manually or semi-automatically delineated liver VOI. The clinical routine pipeline, which involves semi-automatic registration and manual/semi-automatic segmentation, was used as the baseline pipeline and compared to experimental pipelines that use intensity-based deformable automatic registration or deep learning-based automatic segmentation. Dosimetric accuracy was assessed via metrics such as the mean absorbed dose, the minimum dose received by 70% of the volume (D70), and inverted cumulative dose-volume histograms. Results: Semi-automatic and automatic MRI to CT liver registration achieved comparable Dice scores of 92%. However, tumour registration varied significantly between registration methods yielding average Dice scores of 79%. Multimodal tumour segmentation approaches outperformed monomodal ones, achieving average Dice scores of 66.6 versus 62.5%. Using the baseline pipeline, the average tumour absorbed dose per patient was 115.6 Gy. Using the fully automatic approach, tumour absorbed doses differed from baseline values by an average of 6.6 Gy. Differences ranged from 0.3 Gy in the best case to 202.8 Gy when the automatic tumour segmentation markedly deviated from the manual delineation. Finally, it was found that a Dice score of at least 80% was required to avoid statistically significant differences in absorbed dose estimates between the clinical and automatic approaches. Conclusion: Semi-automatic and automatic registration show equivalent performance, allowing for complete automation. Automatic segmentation demonstrates promising results, with approximately 40% of patients achieving tumour Dice scores above the 80% threshold. 30% of cases show intermediate performance (60–80% tumour Dice scores), while the remaining 30% are still challenging. Further refinement of segmentation methods is required to enhance dosimetric accuracy.

  • Open Access

    Tackling data scarcity: Synthetic tumour and mask generation to improve image segmentation

    by Félix Quinton, Benoit Presles, Romain Popoff, François Godard, Olivier Chevallier, Julie Pellegrinelli, Jean-Marc Vrigneaud, Jean-Louis Alberini, Fabrice Meriaudeau

  • Open Access

    Automatic quantification of breast cancer biomarkers from multiple 18F-FDG PET image segmentation

    by Tewele W. Tareke, Neree Payan, Alexandre Cochet, Laurent Arnould, Benoit Presles, Jean-Marc Vrigneaud, Fabrice Meriaudeau, Alain Lalande

    Neoadjuvant chemotherapy (NAC) has become a standard clinical practice for tumor downsizing in breast cancer with 18F-FDG Positron Emission Tomography (PET). Our work aims to leverage PET imaging for the segmentation of breast lesions. The focus is on developing an automated system that accurately segments primary tumor regions and extracts key biomarkers from these areas to provide insights into the evolution of breast cancer following the first course of NAC. 243 baseline 18F-FDG PET scans (PET_Bl) and 180 follow-up 18F-FDG PET scans (PET_Fu) were acquired before and after the first course of NAC, respectively. Firstly, a deep learning-based breast tumor segmentation method was developed. The optimal baseline model (model trained on baseline exams) was fine-tuned on 15 follow-up exams and adapted using active learning to segment tumor areas in PET_Fu. The pipeline computes biomarkers such as maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) to evaluate tumor evolution between PET_Fu and PET_Bl. Quality control measures were employed to exclude aberrant outliers. The nnUNet deep learning model outperformed in tumor segmentation on PET_Bl, achieved a Dice similarity coefficient (DSC) of 0.89 and a Hausdorff distance (HD) of 3.52 mm. After fine-tuning, the model demonstrated a DSC of 0.78 and a HD of 4.95 mm on PET_Fu exams. Biomarkers analysis revealed very strong correlations whatever the biomarker between manually segmented and automatically predicted regions. The significant average decrease of SUVmax, MTV and TLG were 5.22, 11.79 cm3 and 19.23 cm3, respectively. The presented approach demonstrates an automated system for breast tumor segmentation from 18F-FDG PET. Thanks to the extracted biomarkers, our method enables the automatic assessment of cancer progression.

  • Open Access

    PET digitization chain for Monte Carlo simulation in GATE

    by Julien Salvadori, Antoine Merlet, Benoit Presles, Jorge Cabello, Kuan-Hao Su, Alexandre Cochet, Ane Etxebeste, Jean-Marc Vrigneaud, David Sarrut

    Objective. We introduce a versatile methodology for the accurate modelling of PET imaging systems via Monte Carlo simulations, using the Geant4 application for tomographic emission (GATE) platform. Accurate Monte Carlo modelling involves the incorporation of a complete analytical signal processing chain, called the digitizer in GATE, to emulate the different count rates encountered in actual positron emission tomography (PET) systems. Approach. The proposed approach consists of two steps: (1) modelling the digitizer to replicate the detection chain of real systems, covering all available parameters, whether publicly accessible or supplied by manufacturers; (2) estimating the remaining parameters, i.e. background noise level, detection efficiency, and pile-up, using optimisation techniques based on experimental single and prompt event rates. We show that this two-step optimisation reproduces the other experimental count rates (true, scatter, and random), without the need for additional adjustments. This method has been applied and validated with experimental data derived from the NEMA count losses test for three state-of-the-art SiPM-based time-of-flight (TOF)-PET systems: Philips Vereos, Siemens Biograph Vision 600 and GE Discovery MI 4-ring. Main results. The results show good agreement between experiments and simulations for the three PET systems, with absolute relative discrepancies below 3%, 6%, 6%, 7% and 12% for prompt, random, true, scatter and noise equivalent count rates, respectively, within the 0–10 kBq·ml−1 activity concentration range typically observed in whole-body 18F scans. Significance. Overall, the proposed digitizer optimisation method was shown to be effective in reproducing count rates and NECR for three of the latest generation SiPM-based TOF-PET imaging systems. The proposed methodology could be applied to other PET scanners.


  • Open Access

    Validation of a discovery MI 4-ring model according to the NEMA NU 2-2018 standards: from Monte Carlo simulations to clinical-like reconstructions

    by Antoine Merlet, Benoît Presles, Kuan-Hao Su, Julien Salvadori, Farzam Sayah, Hanieh Jozi, Alexandre Cochet, Jean-Marc Vrigneaud

    Background: We propose a comprehensive evaluation of a Discovery MI 4-ring (DMI) model, using a Monte Carlo simulator (GATE) and a clinical reconstruction software package (PET toolbox). The following performance characteristics were compared with actual measurements according to NEMA NU 2-2018 guidelines: system sensitivity, count losses and scatter fraction (SF), coincidence time resolution (CTR), spatial resolution (SR), and image quality (IQ). For SR and IQ tests, reconstruction of time-of-flight (TOF) simulated data was performed using the manufacturer’s reconstruction software. Results: Simulated prompt, random, true, scatter and noise equivalent count rates closely matched the experimental rates with maximum relative differences of 1.6%, 5.3%, 7.8%, 6.6%, and 16.5%, respectively, in a clinical range of less than 10 kBq/mL. A 3.6% maximum relative difference was found between experimental and simulated sensitivities. The simulated spatial resolution was better than the experimental one. Simulated image quality metrics were relatively close to the experimental results. Conclusions: The current model is able to reproduce the behaviour of the DMI count rates in the clinical range and generate clinical-like images with a reasonable match in terms of contrast and noise.


  • Open Access

    Pre-treatment dosimetry in90Y-SIRT: Is it possible to optimise SPECT reconstruction parameters and calculation methods for accurate dosimetry?

    by Tien-Phong Pham, Benoit Presles, Romain Popoff, Jean-Louis Alberini, Jean-Marc Vrigneaud


  • Top Cited Papers
    Open Access

    A Tumour and Liver Automatic Segmentation (ATLAS) Dataset on Contrast-Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma

    by Félix Quinton, Romain Popoff, Benoît Presles, Sarah Leclerc, Fabrice Meriaudeau, Guillaume Nodari, Olivier Lopez, Julie Pellegrinelli, Olivier Chevallier, Dominique Ginhac, et al.

    Liver cancer is the sixth most common cancer in the world and the fourth leading cause of cancer mortality. In unresectable liver cancers, especially hepatocellular carcinoma (HCC), transarterial radioembolisation (TARE) can be considered for treatment. TARE treatment involves a contrast-enhanced magnetic resonance imaging (CE-MRI) exam performed beforehand to delineate the liver and tumour(s) in order to perform dosimetry calculation. Due to the significant amount of time and expertise required to perform the delineation process, there is a strong need for automation. Unfortunately, the lack of publicly available CE-MRI datasets with liver tumour annotations has hindered the development of fully automatic solutions for liver and tumour segmentation. The “Tumour and Liver Automatic Segmentation” (ATLAS) dataset that we present consists of 90 liver-focused CE-MRI covering the entire liver of 90 patients with unresectable HCC, along with 90 liver and liver tumour segmentation masks. To the best of our knowledge, the ATLAS dataset is the first public dataset providing CE-MRI of HCC with annotations. The public availability of this dataset should greatly facilitate the development of automated tools designed to optimise the delineation process, which is essential for treatment planning in liver cancer patients.


  • Critical analysis of the effect of various methodologies to compute breast cancer tumour blood flow-based texture features using first-pass 18F-FDG PET

    by Neree Payan, Benoit Presles, Caroline Truntzer, Emilie Courcet, Charles Coutant, Isabelle Desmoulins, François Brunotte, Jean-Marc Vrigneaud, Alexandre Cochet


  • Open Access

    Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience

    by Julie Pellegrinelli, Olivier Chevallier, Sylvain Manfredi, Inna Dygai-Cochet, Claire Tabouret-Viaud, Guillaume Nodari, François Ghiringhelli, Jean-Marc Riedinger, Romain Popoff, Jean-Marc Vrigneaud, et al.

    Liver tumors are common and may be unamenable to surgery or ablative treatments. Consequently, other treatments have been devised. To assess the safety and efficacy of transarterial radioembolization (TARE) with Yttrium-90 for hepatocellular carcinoma (HCC), liver-dominant hepatic colorectal cancer metastases (mCRC), and cholangiocarcinoma (CCA), performed according to current recommendations, we conducted a single-center retrospective study in 70 patients treated with TARE (HCC, n = 44; mCRC, n = 20; CCA, n = 6). Safety and toxicity were assessed using the National Cancer Institute Common Terminology Criteria. Treatment response was evaluated every 3 months on imaging studies using Response Evaluation Criteria in Solid Tumors (RECIST) or mRECIST criteria. Overall survival and progression-free survival were estimated using the Kaplan-Meier method. The median delivered dose was 1.6 GBq, with SIR-Spheres® or TheraSphere® microspheres. TARE-related grade 3 adverse events affected 17.1% of patients. Median follow-up was 32.1 months. Median progression-free survival was 5.6 months and median overall time from TARE to death was 16.1 months and was significantly shorter in men. Progression-free survival was significantly longer in women (HR, 0.49; 95%CI, 0.26–0.90; p = 0.031). Risk of death or progression increased with the number of systemic chemotherapy lines. TARE can be safe and effective in patients with intermediate- or advanced-stage HCC, CCA, or mCRC refractory or intolerant to appropriate treatments.